Rivaroxaban is an antithrombotic drug with reliable effects.
It is mainly used for the treatment of deep vein thrombosis, pulmonary embolism, for the prevention of venous thrombosis in patients undergoing surgery, and to reduce the possibility of stroke and embolism in the body circulation in patients with non-valvular atrial fibrillation, and it is recommended to use it under the guidance of a doctor.
Rivaroxaban is used for the treatment of deep vein thrombosis and pulmonary embolism. It can be used for elective hip or knee replacement surgery, prophylactic treatment of venous thrombosis. Reduces the likelihood of stroke and physical circulation embolism in patients with non-valvular atrial fibrillation who have one or more risk factors such as: hypertension, age ≥75 years, congestive heart failure, diabetes mellitus, history of stroke or transient ischemic attack.
Adverse Reactions: Sinusitis, oropharyngeal pain, dyspepsia, anxiety, back pain, osteoarthritis, pain in extremities, urinary tract infections, dizziness and insomnia, hemorrhagic strokes and syncope Contraindications: Contraindicated in patients with hypersensitivity to rivaroxaban, in patients with significant active bleeding. Lesions at risk of hemorrhage, gastrointestinal ulcers, intracranial hemorrhage and pregnant and lactating women are contraindicated.
Rivaroxaban, it is recommended to use the drug under medical supervision.